Bioconjugation Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field, including ADCs, oligonucleotide conjugates, protein and peptide conjugates, PEGylation, radioconjugates, conjugated vaccines, diagnostics, and more.
Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation.
We address critical challenges and highlight the latest developments in bioconjugation, publishing original research articles, expert reviews, commentary, case studies, and more. Visit the Bioconjugation Insights Journal page for our comprehensive collection.
Our informative webinar series offers expert-led discussions on significant breakthroughs, novel methodologies, and strategic insights, aimed at supporting continued professional growth and innovation in bioconjugation.
Explore our content for targeted insights into key areas, including conjugation chemistry, analytics, manufacturing processes, and regulatory considerations essential to effective bioconjugate development.
Learn more about our journal’s mission, scope, and publication guidelines by visiting our detailed aims and scope.
Sign-up for free to access our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the forefront of bioconjugation innovation.
If you’re interested in collaborating through sponsorship opportunities, webinars, articles, or other initiatives, please view our media kit to learn more.
Cell & Gene Therapy Insights is an online, open-access, peer-reviewed journal dedicated to the interdisciplinary exploration and advancement of cell and gene therapy. With a translational focus, we connect innovative research to practical clinical applications, providing valuable insights into one of biotechnology’s fastest-evolving fields.
We address the key challenges and latest developments across advanced therapies, publishing original research articles, expert reviews, commentary, clinical trial reports, and more. Visit the Cell & Gene Therapy Insights Journal page for our complete collection.
Our popular webinar series provides expert-led discussions on important developments and methodologies in the field, designed to support ongoing professional growth.
Explore our specialised channels, including detailed coverage of critical areas like the cell and gene supply chain, for targeted insights into manufacturing, logistics, and regulatory frameworks essential to therapy commercialisation.
Learn more about our journal’s mission and publishing criteria by visiting our aims and scope.
Sign-up for free to gain unlimited access to our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the forefront of cell and gene therapy innovation.
If you’re interested in working with us, from sponsoring articles to webinars and more, view the media kit to find out more.
Nucleic Acid Insights covers the latest news, trends, issues, and breakthroughs across the rapidly evolving nucleic acids space, including oligonucleotides, mRNA, DNA, formulation and delivery, and more.
Our content - a balance of high-level analysis and in-depth technical data - is designed to give you the understanding and need-to-know information you require to successfully navigate this rapidly evolving space.
We cover critical challenges and the latest innovations in nucleic acid therapies, publishing original research articles, expert reviews, commentary, clinical reports, and more. Visit the Nucleic Acid Insights Journal page for our complete collection.
Our engaging webinar series provides expert-led discussions on significant developments, novel methodologies, and emerging trends, designed to support continued professional growth in nucleic acid research.
Explore our specialised channels, including focused coverage of key areas such as mRNA technology, plasmid DNA production, and oligonucleotide therapeutics, offering targeted insights into manufacturing, delivery, and regulatory considerations critical to therapeutic development.
Learn more about our journal’s mission and publishing criteria by visiting our aims and scope.
Sign-up for free to gain unlimited access to our extensive library of articles, webinars, podcasts, news, and interviews, and stay at the cutting edge of nucleic acid innovation.
If you’re interested in partnering with us through sponsorships, webinars, articles, and more, please view our media kit to learn more.
Closed Publications
Immuno-Oncology Insights has ceased publication. However, all published content remains available here. |
Immuno-Oncology Insights was an open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the slate of journals for the industrial and academic and immuno-oncology communities.
Guided by an editorial board lead by Jon Wigginton and Renier J Brentjens, Immuno-Oncology Insights placed R&D and manufacturing challenges and progress across a wide variety of technology fields in context.
To find out more or to access some of our fantastic content, visit Immuno-Oncology Insights.